fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55      »      [57]
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2007-05-24 I-II Result Cytos Biotechnology (Switzerland)   CYT007-TNFQb psoriasis   See details
2007-05-18 I Result Intercell (Austria) Merck&Co vaccine against Staphylococcus aureus     See details
2007-05-17 I Launch Phytopharm (UK)   Myogane® (a non-peptide inducer of neurotrophic factor) amyotrophic lateral sclerosis aka Lou Gehrig's disease United Kingdom See details
2007-05-11 I Launch Crucell (The Netherlands)   AERAS-402/Ad35 vaccine tuberculosis South Africa See details
2007-05-03 III Launch Pharmexa (Denmark)   GV1001 (peptide vaccine for the activation of T lymphocytes) pancreatic cancer USA See details
2007-05-02 I-II Launch TopoTarget (Denmark)/Curagen (USA)   belinostat (PXD101 - histone deacetylase inhibitor) in combination with doxorubicin soft tissue sarcoma United Kingdom and Denmark See details
2007-05-02 III Result Newron (Italy) Merck Serono (Switzerland) safinamide symptoms of Parkinson's disease   See details
2007-05-01 I Result deCODE Genetics (Iceland)   DG051 (leukotriene A4 hydrolase inhibitor) prevention of heart attacks   See details
2007-04-30 II Launch JADO Technologies (Germany)   TF002 cutaneous mastocytosis Germany See details
2007-04-30 I Launch Pharmexa-Epimmune (USA-Denmark) Bavarian Nordic (Denmark)   combination of two vaccine candidates, EP1233 and MVA-BN AIDS USA See details
2007-04-26 II Launch Innate Pharma (France)   IPH 1101 (the most advanced candidate from Innate Pharma's gamma-delta platform) hepatitis C   See details
2007-04-24 II Launch TopoTarget (Denmark)   Avugane® (valproic acid) acne Denmark See details
2007-04-13 II Launch MediGene (Germany)   EndoTag®1 (paclitaxel encapsulated in a cationic lipid complex delivery system) Receptor-negative breast cancer (i.e. no oestrogen receptors or HER-2 receptors) several European countries, India See details
2007-04-13 I Result Hybrigenics (France)   inecalcitol The molecule targets indications in oncology, in particular in hormone-therapy-resistant prostate cancer. France See details
2007-04-12 II Launch Genmab (Denmark)   HuMax-EGFr® (zalutumumab) non-small-cell lung cancer USA See details
[<<]      «      45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55      »      [57]